Vertex Pharmaceuticals Stock (NASDAQ: VRTX) stock price, news, charts, stock research, profile.
You can purchase shares of Vertex Pharmaceuticals (NASDAQ:VRTX) through any online brokerage.
Other companies in Vertex Pharmaceuticals’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
Vertex Pharmaceuticals has a consensus price target of $505.04.
The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $491.4738 last updated November 12, 2024 at 7:28 PM EST.
There are no upcoming dividends for Vertex Pharmaceuticals.
Vertex Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 3, 2025.
There is no upcoming split for Vertex Pharmaceuticals.
Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.